Guangdong Taiantang Pharmaceutical Co., Ltd.

    Guangdong Taiantang Pharmaceutical Co., Ltd.

    SSZSE:002433
    0.27
    CNY
    -0.03
    (-10.00%)
    2011 Y
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    TTM
    Revenue per Share
    1.04
    1.29
    1.42
    1.98
    3.24
    4.04
    4.24
    4.28
    5.43
    4.83
    2.96
    0.84
    0.53
    0.43
    Basic EPS, GAAP
    0.19
    0.22
    0.24
    0.3
    0.26
    0.32
    0.38
    0.35
    0.13
    0.03
    -1.05
    -1.26
    -2.88
    -2.81
    Free Cash Flow per Basic Share
    -0.57
    -0.51
    -0.87
    -0.75
    -2.23
    -0.9
    -0.78
    -0.11
    0.29
    -0.41
    1.06
    0.28
    -0.17
    -0.03
    Dividend per Share
    0.13
    0.05
    0.04
    0.07
    0.04
    0.06
    0.15
    0.17
    0.26
    0.2
    0.23
    0.13
    0.1
    0.07
    Book Value per Share
    0.69
    0.99
    1.13
    1.98
    1.97
    2.18
    2.5
    2.79
    2.96
    2.97
    1.83
    -0.52
    -3.4
    -3.4
    Tangible Book Value per Share
    1.97
    4.2
    3.29
    4.82
    5.11
    5.23
    5.54
    5.87
    6.25
    6.26
    5.57
    3.15
    0.25
    0.18
    Basic Weighted Avg Shares
    401
    400
    554
    621
    731
    760
    764
    774
    739
    741
    765
    768
    767
    783
    Sales/Revenue/Turnover
    417
    518
    785
    1,228
    2,372
    3,075
    3,239
    3,315
    4,013
    3,582
    2,264
    646
    410
    340
    Operating Margin (%)
    20.41
    25.52
    21.59
    19.28
    9.72
    10.68
    12.84
    7.66
    6.16
    4.1
    -3.88
    -24.56
    -87.37
    -98.5
    Depreciation Expense
    14
    26
    37
    48
    51
    54
    76
    84
    96
    106
    131
    128
    107
    - -
    Net Income, GAAP
    74
    88
    133
    186
    190
    243
    290
    271
    96
    22
    -803
    -968
    -2,210
    -2,203
    Effective Tax Rate (%)
    15.3
    19.18
    12.26
    7.42
    11.94
    14.32
    16.91
    16.25
    17.96
    29.32
    - -
    - -
    - -
    - -
    Profit Margin (%)
    17.77
    17
    16.93
    15.18
    8.02
    7.91
    8.97
    8.17
    2.39
    0.62
    -35.48
    -149.98
    -538.57
    -648.74
    Working Capital
    402
    1,042
    832
    2,214
    2,626
    2,996
    2,378
    2,273
    2,050
    1,103
    2,468
    698
    -1,150
    -1,191
    LT Debt
    - -
    70
    73
    25
    7
    934
    1,025
    974
    998
    2
    29
    5
    75
    74
    Total Equity
    1,010
    1,913
    2,042
    3,775
    4,510
    4,742
    5,027
    5,319
    5,397
    5,421
    4,584
    2,718
    396
    341
    Return on Invested Capital (%)
    6.43
    6.44
    6.72
    6.92
    4.49
    4.99
    5.07
    2.8
    2.66
    1.35
    - -
    - -
    - -
    - -
    Return on Capital (%)
    18.73
    17.84
    17.36
    15.92
    10.91
    10.73
    9.55
    8.23
    4.44
    2.43
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    27.37
    26.05
    25.99
    20.11
    14.24
    15.71
    16.3
    13.33
    4.42
    1.01
    -44.67
    - -
    - -
    -246.79

    Capital Structure

    CNY

    •

    in mil. unless spec.
    Sep'23
    Dec'23
    Mar'24
    ST Debt
    823
    1,177
    1,175
    LT Borrowings
    1
    - -
    - -
    LT Finance Leases
    - -
    75
    74
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    767
    767
    767
    Market Capitalization
    2,435
    1,820
    971

    Working Capital

    CNY

    •

    in mil. unless spec.
    Sep'23
    Dec'23
    Mar'24
    Total Current Assets
    3,428
    1,188
    1,144
    Cash, Cash Equivalents & STI
    34
    123
    94
    Accounts Receivable, Net
    286
    146
    156
    Inventories
    2,261
    510
    518
    Total Current Liabilities
    1,716
    2,338
    2,335
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    823
    1,177
    1,175
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CNY

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    -1.83%
    -27.94%
    -85.44%
    Free Cash Flow
    -111.05%
    -239.96%
    -158.81%
    Net Income, GAAP
    -362.4%
    -741.37%
    128.28%
    Sales/Revenue/Turnover
    5.25%
    -26.88%
    -36.43%
    Total Cash Common Dividend
    25.2%
    -5.65%
    -26.68%

    Quarterly Revenue

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    191
    318
    189
    -53
    646
    2023
    139
    122
    117
    32
    410
    2024
    69
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.05
    - -
    - -
    - -
    -1.26
    2023
    -0.08
    - -
    - -
    - -
    -2.88
    2024
    -0.07
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    0.03
    - -
    - -
    - -
    0.13
    2023
    0.03
    - -
    - -
    - -
    0.1
    2024
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business